Antimicrobial Agents and Chemotherapy
短名 | Antimicrob Agents Chemother |
Journal Impact | 4.06 |
国际分区 | PHARMACOLOGY & PHARMACY(Q1) |
期刊索引 | SCI Q1中科院 2 区 |
ISSN | 0066-4804, 1098-6596 |
h-index | 289 |
国内分区 | 医学(2区)医学药学(1区)医学微生物学(2区) |
Top期刊 | 是 |
抗菌药物和化疗 (AAC) 以跨学科研究为特色,帮助我们了解抗菌和抗寄生虫药物和化疗的潜在机制和治疗应用。
期刊主页涉及主题 | 生物遗传学化学生物化学微生物学医学地质学古生物学抗生素细菌基因内科学有机化学免疫学药理学病理大肠杆菌病毒学体外 |
出版信息 | 出版商: American Society for Microbiology,出版周期: Monthly,期刊类型: journal |
基本数据 | 创刊年份: 1972,原创研究文献占比: 97.43%,自引率:7.30%, Gold OA占比: 29.58% |
平均审稿周期 | 网友分享经验:平均3.0个月 |
平均录用比例 | 网友分享经验:约37.5% |
期刊引文格式
这些示例是对学术期刊文章的引用,以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章,因此这些字段是可选的。有些电子期刊不提供页面范围,而是列出文章标识符。在这种情况下,使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用,以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Gentamicin and clindamycin antibiotic-eluting depot technology eradicates <i>S. aureus</i> in an implant-associated osteomyelitis pig model without systemic antibiotics
2024-9-17
Novel humanized anti-PcrV monoclonal antibody COT-143 protects mice from lethal <i>Pseudomonas aeruginosa</i> infection via inhibition of toxin translocation by the type III secretion system
2024-9-13
<i>In vitro</i> antimalarial susceptibility profile of <i>Plasmodium falciparum</i> isolates in the BEI Resources repository
2024-9-13
Recent increase in <i>Candida auris</i> frequency in the SENTRY surveillance program: antifungal activity and genotypic characterization
2024-9-12
An adaptable, fit-for-purpose screening approach with high-throughput capability to determine speed of action and stage specificity of anti-malarial compounds
2024-9-12
Anti-echinococcal effect of metformin in advanced experimental cystic echinococcosis: reprogrammed intermediary carbon metabolism in the parasite
2024-9-12
The OprF porin as a potential target for the restoration of carbapenem susceptibility in <i>Pseudomonas aeruginosa</i> expressing acquired carbapenemases
2024-9-12
Erratum for Yang et al., “A phase I study of the safety, tolerability, and pharmacokinetics of contezolid acefosamil after intravenous and oral administration in healthy Chinese subjects”
2024-9-12
Evolution toward extremely high imipenem resistance in <i>Mycobacterium abscessus</i> outbreak strains
2024-9-10
Synergistic antimicrobial combination of third-generation cephalosporins and polymyxin B against carbapenem-polymyxin-resistant <i>Klebsiella pneumoniae:</i> an <i>in vitro</i> and <i>in vivo</i> analysis
2024-9-10
Molecular characterization of clinically isolated <i>Pseudomonas aeruginosa</i> with varying resistance to ceftazidime-avibactam and ceftolozane-tazobactam collected as a part of the ATLAS global surveillance program from 2020 to 2021
2024-9-10
A high content imaging assay for identification of specific inhibitors of native <i>Plasmodium</i> liver stage protein synthesis
2024-9-10
Zebrafish as an effective model for evaluating phage therapy in bacterial infections: a promising strategy against human pathogens
2024-9-9
Polymyxins retain <i>in vitro</i> activity and <i>in vivo</i> efficacy against “resistant” <i>Acinetobacter baumannii</i> strains when tested in physiological conditions
2024-9-6
Oral pharmacokinetics and efficacy of oral phospholipid remdesivir nucleoside prodrugs against SARS-CoV-2 in mice
2024-9-6
High salt condition alters LPS synthesis and induces the emergence of drug resistance mutations in <i>Helicobacter pylori</i>
2024-9-6
Incidence of serotonin syndrome in patients receiving tedizolid and concomitant serotonergic agents
2024-9-5
IMT-P8 potentiates Gram-positive specific antibiotics in intrinsically resistant Gram-negative bacteria
2024-9-5
Clinical outcomes and emergence of resistance of <i>Pseudomonas aeruginosa</i> infections treated with ceftolozane-tazobactam versus ceftazidime-avibactam
2024-9-4
Discovery of new acetamide derivatives of 5-indole-1,3,4-oxadiazol-2-thiol as inhibitors of HIV-1 Tat-mediated viral transcription
2024-9-4
Evaluating nephrotoxicity reduction in a novel polymyxin B formulation: insights from a 3D kidney-on-a-chip model
2024-9-3
Design of novel and highly selective SARS-CoV-2 main protease inhibitors
2024-9-3
The fungal natural product fusidic acid demonstrates potent activity against <i>Mycoplasma genitalium</i>
2024-8-29
Efficacy of ensitrelvir for cough due to COVID-19 Omicron variant in medical healthcare workers
2024-8-29
Identification of novel and potent inhibitors of SARS-CoV-2 main protease from DNA-encoded chemical libraries
2024-8-28
Onametostat, a PfPRMT5 inhibitor, exhibits antimalarial activity to <i>Plasmodium falciparum</i>
2024-8-28
Dose-fractionation studies of a <i>Plasmodium</i> phosphatidylinositol 4-kinase inhibitor in a humanized mouse model of malaria
2024-8-28
Loss of glycerol catabolism confers carbon-source-dependent artemisinin resistance in <i>Mycobacterium tuberculosis</i>
2024-8-28
Zidovudine in synergistic combination with nitrofurantoin or omadacycline: <i>in vitro</i> and in murine urinary tract or lung infection evaluation against multidrug-resistant <i>Klebsiella pneumoniae</i>
2024-8-28
Application of machine-learning models to predict the ganciclovir and valganciclovir exposure in children using a limited sampling strategy
2024-8-28
The novel MFS efflux pump SxtP, regulated by the LysR-type transcriptional activator SxtR, is involved in the susceptibility to sulfamethoxazole/trimethoprim (SXT) and the pathogenesis of <i>Acinetobacter baumannii</i>
2024-8-28
Pharmacokinetics and safety of TBAJ-876, a novel antimycobacterial diarylquinoline, in healthy subjects
2024-8-28
Osteomyelitis-relevant antibiotics at clinical concentrations show limited effectivity against acute and chronic intracellular <i>S. aureus</i> infections in osteocytes
2024-8-28
Automated calculation and reporting of vancomycin area under the concentration–time curve: a simplified single-trough concentration-based equation approach
2024-8-28
IncC plasmid genome rearrangements influence the vertical and horizontal transmission tradeoff in <i>Escherichia coli</i>
2024-8-28
Adjuvants restore colistin sensitivity in mouse models of highly colistin-resistant isolates, limiting bacterial proliferation and dissemination
2024-8-28
Retrospective validation study of a machine learning-based software for empirical and organism-targeted antibiotic therapy selection
2024-8-28
<i>Acinetobacter baumannii</i> transformants expressing oxacillinases and metallo-β-lactamases that confer resistance to meropenem: new tools for anti- <i>Acinetobacter</i> drug development and AMR preparedness
2024-8-27
Deoxyshikonin: a promising lead drug grass against drug resistance or sensitivity to <i>Helicobacter pylori</i> in an acidic environment
2024-8-22
Use of frozen native feces for fecal microbiota transplantation in recurrent <i>Clostridioides difficile</i> infection: a simple way to improve the efficiency of donor feces preparation
2024-8-21
A molecular analysis of meropenem–vaborbactam non-susceptible KPC-producing <i>Klebsiella pneumoniae</i>
2024-8-20
Structural basis of paramyxo- and pneumovirus polymerase inhibition by non-nucleoside small-molecule antivirals
2024-8-20
Multicenter evaluation of activity of aztreonam in combination with avibactam, relebactam, and vaborbactam against metallo-β-lactamase-producing carbapenem-resistant gram-negative bacilli
2024-8-19
Systemic absorption and safety of topical terbinafine hydrochloride 10% solution (MOB015B): a phase 1 maximal usage trial in patients with moderate-to-severe onychomycosis
2024-8-19
Zap the clap with DNA: a novel microbicide for preventing <i>Neisseria gonorrhoeae</i> infection
2024-8-16
Development of non-sedating benzodiazepines with <i>in vivo</i> antischistosomal activity
2024-8-13
Bacteriophage therapy reduces <i>Staphylococcus aureus</i> in a porcine and human <i>ex vivo</i> burn wound infection model
2024-8-13
<i>In vitro</i> efficacy of next-generation dihydrotriazines and biguanides against babesiosis and malaria parasites
2024-8-13
Prevalence and dynamics of antimalarial drug resistance mutations among the <i>Plasmodium falciparum</i> isolates in TAK Province, Thailand, during the period of 1998–2001
2024-8-13
A retrospective analysis of <i>P. falciparum</i> drug resistance markers detects an early (2016/17) high prevalence of the k13 C469Y mutation in asymptomatic infections in Northern Uganda
2024-8-13
帮你贴心管理全部的文献
研飞ivySCI,高效的论文管理
投稿经验分享
分享我的经验,帮你走得更远